BAA project titled, "bridging novel laboratory animal and hollow fiber infection models to evaluate central nervous system penetration of drugs in infants."
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201610082C
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $629,800
Award facts
- Opportunity
-
- FDABAA16000122 Solicitation number
- Contract value 100% obligated
- $629,799.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27708, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$24,901 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $654,701 |
About this award
This is a $629,799.52 federal contract awarded by the Food and Drug Administration (FDA) to Duke University, a private university and non-profit organization. The contract is for a project titled "Bridging Novel Laboratory Animal and Hollow Fiber Infection Models to Evaluate Central Nervous System Penetration of Drugs in Infants." The contract is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of September 29, 2020. There was no set-aside used for this award.
The University of Liverpool was awarded a $2,038,366 subcontract under this award to develop and validate a rabbit model of central nervous system infection and define the pharmacodynamics of certain antibiotics for the treatment of meningitis. This demonstrates Duke University's ability to collaborate with other research institutions on federal contracts. The contract aligns with the FDA's interests in evaluating drug penetration in the central nervous system, particularly for pediatric populations.
Quick answers
Who was awarded contract HHSF223201610082C?
HHSF223201610082C was awarded to Duke University by Food and Drug Administration (Department of Health and Human Services) on August 29, 2016.
How much is contract HHSF223201610082C worth?
The government has obligated $629,800 on HHSF223201610082C.
Was contract HHSF223201610082C competed?
The extent of competition for HHSF223201610082C was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award